Here’s another example of established digital health entities gaining strength by working together. Cloud-based virtual care company eCare21announced its use of BioIntellisense smart wearables for remote patient monitoring.

eCare21 provides end-to-end virtual patient care for healthcare providers. eCare21’s solution combines remote patient monitoring (RPM), chronic care management, virtual visits, and clinical data for home-based patients. Healthcare providers employ eCare21’s services to manage chronic conditions remotely, improve care decisions, reduce hospitalizations, and bridge information gaps.

eCare21 will use BioIntelliSense BioSticker and BioButton biosensor wearables and data services. BioIntellisense combines medical-grade biosensors and data analytics. eCare21 plans to use BioIntelliSense technology to support and accelerate enterprise deployments. We wrote about the BioIntelliSense BioSticker and BioButton in 2020 and again at the end of the year when the company won a CES 2021 Best of Innovation Award. In January 2021 Royal Philips announced its own collaboration with BioIntellisense for RPM.

The latest announcement shows two significant digital health companies strengthening their respective positions by collaborating. As we’ve written previously, such partnerships indicate a maturing digital health market segment.